指南与共识肾移植

肾移植移植物管理中的挑战:从功能减退到衰竭——KDIGO争议会议结论

Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
指南 / 共识 · Kidney Int · 2023-05-24

2022年3月,KDIGO召开线上争议会议,聚焦肾移植移植物功能衰竭或已衰竭阶段的管理。会议讨论了衰竭移植物的定义、预后与肾衰竭轨迹、免疫抑制策略、医疗与心理并发症管理及患者因素、移植肾丢失后肾脏替代治疗或支持治疗的选择,强调患者中心、心理准备、早期沟通和透析通路准备。

要点

  • 识别并特别关注移植物功能衰竭患者,以进行心理准备、免疫抑制管理、并发症处理及透析或再移植准备。
  • 移植肾衰竭后是否撤除或继续免疫抑制,应基于风险-获益分析及数月内再移植可能性决定。
  • 强调透析开始前做好透析通路准备,以避免使用中心静脉导管。

核心结论

  • 识别并特别关注移植物功能衰竭患者对心理准备、免疫抑制管理、并发症处理、透析和/或再移植准备及向支持治疗过渡很重要。
  • 移植肾衰竭后是否撤除或继续免疫抑制,最恰当的依据是风险-获益分析及数月内再移植的可能性。
  • 心理准备和支持以及早期沟通是患者适应移植物衰竭的关键因素。

研究设计与样本

  • 2022年3月,肾脏病改善全球预后组织(KDIGO)召开线上争议会议,讨论肾移植移植物功能衰竭或已衰竭阶段的管理。

主要发现

  • 会议讨论了衰竭移植物的定义,并在移植肾功能减退背景下考虑了4个广泛领域:预后与肾衰竭轨迹、免疫抑制策略、医疗和心理并发症及患者因素的管理、移植物丢失后肾脏替代治疗或支持治疗的选择。
  • 准确的预后工具虽尚未广泛可用,但被认为对定义移植物存活轨迹和移植物衰竭可能性是必要的。
  • 若干照护模式被认为有助于向透析或再移植的医学支持性过渡。
  • 会议强调患者在所有管理决策和讨论中的中心地位,患者「激活」被视为取得成功的最有效方式。

临床怎么用

  • 识别并特别关注移植物功能衰竭患者,以进行心理准备、免疫抑制管理、并发症处理、透析和/或再移植准备及向支持治疗过渡。
  • 移植肾衰竭后是否撤除或继续免疫抑制,基于风险-获益分析及数月内再移植的可能性决定。
  • 强调透析开始前做好透析通路准备,以避免使用中心静脉导管。
  • 患者应处于所有管理决策和讨论的中心。

局限性

  • 会议强调了未解决的争议、知识空白和研究领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In March 2022, Kidney Disease: Improving Global Outcomes (KDIGO) held a virtual Controversies Conference to address the important but rarely examined phase during which the kidney transplant is failing or has failed. In addition to discussing the definition of a failing allograft, 4 broad areas were considered in the context of a declining functioning graft: prognosis and kidney failure trajectory; immunosuppression strategies; management of medical and psychological complications, and patient factors; and choice of kidney replacement therapy or supportive care following graft loss. Identifying and paying special attention to individuals with failing allografts was felt to be important in order to prepare patients psychologically, manage immunosuppression, address complications, prepare for dialysis and/or retransplantation, and transition to supportive care. Accurate prognostication tools, although not yet widely available, were embraced as necessary to define allograft survival trajectories and the likelihood of allograft failure. The decision of whether to withdraw or continue immunosuppression after allograft failure was deemed to be based most appropriately on risk-benefit analysis and likelihood of retransplantation within a few months. Psychological preparation and support was identified as a critical factor in patient adjustment to graft failure, as was early communication. Several models of care were noted that enabled a medically supportive transition back to dialysis or retransplantation. Emphasis was placed on the importance of dialysis-access readiness before initiation of dialysis, in order to avoid use of central venous catheters. The centrality of the patient to all management decisions and discussions was deemed to be paramount. Patient "activation," which can be defined as engaged agency, was seen as the most effective way to achieve success. Unresolved controversies, gaps in knowledge, and areas for research were also stressed in the conference deliberations.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Josephson MA, Becker Y, Budde K, et al. Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023. PMID: 37236423. doi:10.1016/j.kint.2023.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。